Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-03-03

Clinical Trial Update: An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety of the fentanyl transdermal system for acute postoperative pain in pediatric patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fentanyl Transdermal System (fentanyl)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Pain, Postoperative, Pediatrics | Phase 3 | Status: WITHDRAWN